Skip to main content

Table 1 Immunohistochemical antibodies used to characterize the luminal cases

From: Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer

Protein (Clone)

Antibody

Origin

Clone

Pre-treatment

Dilution

Location of staining

Normal

Androgen receptor

(AR)

mmb

Dako

4AR441

PH9

Target retrieval solution

(98°C, 40 min)

1/50°

nucleus

+

BCL2

mmb

Dako

124

Citrate*

1/100°

cytoplasm

+

CyclinD1

CCND1

mmb

Labvision

SP4

EDTA*

prediluted

nucleus

+

ERBB2

mmb

Dako

Herceptest Ltd

AO485

Target retrieval *

1/500

membrane

-

Estrogen receptor (ER)

mmb

Novocastra laboratories Ltd

6F11.2

Target retrieval *

1/60

nucleus

+

FOXA1

mmb

AbNova

2D7

Citrate*

1/250

nucleus

+

GATA3

mmb

Santacruz

HG3-31

Citrate*

1/100°

nucleus

+

P53

mmb

Beckmann

DO-1

Citrate*

1/4

nucleus

-

Progesterone

receptor (PR)

mmb

Dako

PFR 636

Target retrival *

1/80

nucleus

+

Ki67

mmb

Dako

KI-67

Target retrieval solution *

1/100

nuclear

+

  1. + = positive expression, - = negative expression.
  2. The asterisk symbols mean that it is a buffer solution.